Literature DB >> 9117261

Brain aggrecan.

N B Schwartz1, M Domowicz, R C Krueger, H Li, D Mangoura.   

Abstract

During development, the extracellular matrix (ECM) is a complex dynamic structure whose components and organization help to establish the requisite position and state of differentiation. Until recently, the large chondroitin sulfate proteoglycan, aggrecan, has been localized predominantly to skeletal tissue and considered a hallmark of cartilage differentiation. We have identified the presence of aggrecan in two other highly differentiated systems, brain and notochord, with clearly distinct expression patterns. In chick cartilage, aggrecan starts to be expressed at embryonic day 5 in limb rudiments, continues through the entire period of chondrocyte development, and remains a biochemical marker of the cartilage phenotype thereafter. In brain, aggrecan has a very low level of expression beginning at day 7, increases up to day 13, markedly decreases after day 16, and is not expressed posthatching. This pattern coincides with migration and establishment of neuronal nuclei in the chick telencephalon and has been proposed to be a component of the migration arrest mechanism. In very primitive embryos, aggrecan is detected as early as stage 16 in the notochord, long before chondrogenesis occurs, is then expressed up to day 5 and decreases thereafter. The expression of aggrecan occurs during the time of active neural crest migration and through the onset of sclerotomal differentiation, and correlates with the notochords' ability to inhibit neural crest cell migration. Animal models defective in aggrecan biosynthesis have been invaluable in delineating these functions. In addition we have characterized these proteoglycans by chemical, biosynthetic, and molecular analyses. Although significant post-translation differences distinguish the cell-specific aggrecan species, their core proteins are the products of a single gene. Our findings of the expression of the same gene (aggrecan) in multiple ontogenously unrelated differentiating tissue systems and at different times over the developmental life of an organism provide an elegant model system to study the regulation and interplay in expression of that gene, as well as the effect of alterations in that single gene simultaneously in several developing programs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9117261

Source DB:  PubMed          Journal:  Perspect Dev Neurobiol        ISSN: 1026-7697


  10 in total

1.  Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury.

Authors:  M L Lemons; J D Sandy; D K Anderson; D R Howland
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

2.  Embryonic neurons adapt to the inhibitory proteoglycan aggrecan by increasing integrin expression.

Authors:  M L Condic; D M Snow; P C Letourneau
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

3.  Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord.

Authors:  Arsen S Hunanyan; Guillermo García-Alías; Valentina Alessi; Joel M Levine; James W Fawcett; Lorne M Mendell; Victor L Arvanian
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 4.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

Review 5.  Proteoglycans in brain development.

Authors:  Nancy B Schwartz; Miriam Domowicz
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Biodegradable polymers in chondrogenesis of human articular chondrocytes.

Authors:  Nasreen Banu; Yasmin Banu; Masamune Sakai; Tadahiko Mashino; Toshie Tsuchiya
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

7.  A comprehensive atlas of Aggrecan, Versican, Neurocan and Phosphacan expression across time in wildtype retina and in retinal degeneration.

Authors:  A Matsuyama; A A Kalargyrou; A J Smith; R R Ali; R A Pearson
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

8.  PKCε signalling activates ERK1/2, and regulates aggrecan, ADAMTS5, and miR377 gene expression in human nucleus pulposus cells.

Authors:  Emmanouella Tsirimonaki; Constantinos Fedonidis; Spiros G Pneumaticos; Adamantios A Tragas; Ioannis Michalopoulos; Dimitra Mangoura
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

9.  Müller glia activation in response to inherited retinal degeneration is highly varied and disease-specific.

Authors:  Claire Hippert; Anna B Graca; Amanda C Barber; Emma L West; Alexander J Smith; Robin R Ali; Rachael A Pearson
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 10.  Aggrecan, the Primary Weight-Bearing Cartilage Proteoglycan, Has Context-Dependent, Cell-Directive Properties in Embryonic Development and Neurogenesis: Aggrecan Glycan Side Chain Modifications Convey Interactive Biodiversity.

Authors:  Anthony J Hayes; James Melrose
Journal:  Biomolecules       Date:  2020-08-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.